Carbutamide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.
It is classified as first-generation.[1]
References
- ↑ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). “Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds”. Diabetes Res. Clin. Pract. 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH